openPR Logo
Press release

Systemic Lupus Erythematosus - Drug Pipeline Landscape, 2022

12-01-2022 03:57 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Global Insight Services

Systemic Lupus Erythematosus - Drug Pipeline Landscape, 2022

Systemic Lupus Erythematosus - Drug Pipeline Landscape, 2022

Systemic lupus erythematosus (SLE) also referred as lupus. It is a chronic, inflammatory autoimmune disease with multiorgan involvement. In this condition, the body attacks its own immune system and causes inflammation as well as tissue damage.

The main goal of the SLE treatment is to avoid known triggering factors, preventing from tissue damage, reducing comorbidities secondary to lupus and addressing fatigue and pain. And the treatment also based on the organs and systems involved as well as the severity. Mild to moderate lupus condition can be treated with NSAIDs, anti-malarial agents and corticosteroids, in severe conditions immunosuppressive agents are included.

To know more about Systemic Lupus Erythematosus's pipeline, visit - https://www.globalinsightservices.com/reports/systemic-lupus-erythematosus-drug-pipeline-landscape-2022/

The exact cause of SLE condition is still unknown. Main factors associated with disease development and activity are environmental triggers, genetic predisposition and hormonal milieu interplay.

The common symptoms associated with SLE are inflamed joints, fatigue, fever, mouth ulcers, swollen lymph nodes, hair loss, chest pain, rashes mostly on face and anemia.

The primary diagnosis of SLE can be determined by any of the symptoms and signs. The diagnosis also involves physical examination, blood and urine tests, and skin or kidney biopsy. Other tests that are involved in confirming the severity are antinuclear antibodies (ANA) and anti-double stranded (ds) DNA (anti-dsDNA) test, CBC with differentials, urine analysis and chemistry profile including renal and liver enzymes.

To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS31103

Report Segmentation
Assessment by Stage of Development
Assessment by Companies
Assessment by Target
Assessment by Mechanism of Action
Assessment by Molecule Type
Assessment by Route of Administration

Key Players
• AbbVie
• Abcentra LLC
• Accro BioScience (Suzhou) Co Ltd
• Alexion Pharmaceuticals
• Aluda Pharmaceuticals Inc
• Amgen Inc
• Ampio Pharmaceuticals Inc
• ANNEXON INC
• Apellis Pharmaceuticals, Inc
• Aria Pharmaceuticals Inc
• Asahi Kasei Pharma Corporation
• AstraZeneca
• Athos Therapeutics
• Aurinia Pharmaceuticals Inc
• Avotres Inc
• BeiGene
• Beijing Mabworks Biotech Co Ltd

Get Customized Report as Per Your Requirement - https://www.globalinsightservices.com/inquiry-before-buying/GIS31103

Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

For In-Depth Competitive Analysis, Purchase this Report - https://www.globalinsightservices.com/inquiry-before-buying/GIS31103

With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
and transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Systemic Lupus Erythematosus - Drug Pipeline Landscape, 2022 here

News-ID: 2829537 • Views:

More Releases from Global Insight Services

Governance Risk and Compliance (GRC) Platform Market to Expand From $53.5 Billion in 2024 to $152 Billion by 2034 With 11% CAGR
Governance Risk and Compliance (GRC) Platform Market to Expand From $53.5 Billio …
The Governance Risk And Compliance (GRC) Platform Market has emerged as a cornerstone for organizations striving to enhance accountability, streamline risk management, and meet growing regulatory demands. GRC platforms provide an integrated framework that enables companies to monitor compliance, manage risks, and ensure governance practices are aligned with industry standards. By combining risk assessment, audit management, compliance tracking, and policy enforcement, these platforms empower businesses to strengthen decision-making and safeguard
Electronic Manufacturing Services (EMS) Market to Expand From $504.22 Billion in 2024 to $1,072.15 Billion by 2034 With 7.8% CAGR
Electronic Manufacturing Services (EMS) Market to Expand From $504.22 Billion in …
The Electronic Manufacturing Services (EMS) Market has become one of the most crucial sectors in the global technology-driven economy. EMS refers to the outsourcing of design, production, testing, and distribution of electronic components for original equipment manufacturers (OEMs). These services are indispensable across industries such as consumer electronics, automotive, telecommunications, and healthcare. In 2024, the EMS sector continues to play a pivotal role in improving efficiency, lowering production costs, and
Catamaran Market Is Anticipated To Expand From $4.2 Billion In 2024 To $7.8 Billion By 2034
Catamaran Market Is Anticipated To Expand From $4.2 Billion In 2024 To $7.8 Bill …
Market Overview The Catamaran Market is witnessing remarkable expansion, driven by the growing demand for recreational boating, marine tourism, and eco-friendly vessel options. Catamarans, recognized for their stability, spaciousness, and fuel efficiency, are increasingly preferred for leisure sailing, luxury tourism, and competitive racing. The market includes a wide range of offerings such as sailing catamarans, power catamarans, luxury yachts, and charter vessels, each catering to unique consumer preferences. Innovations in sustainable
Gear Motor Market to Expand From $24.5 Billion in 2024 to $39.8 Billion by 2034 With 5% CAGR
Gear Motor Market to Expand From $24.5 Billion in 2024 to $39.8 Billion by 2034 …
The gear motor market is witnessing steady growth as industries worldwide increasingly depend on reliable and energy-efficient motion control systems. Gear motors, which combine a motor with a gearbox, play a vital role in converting electrical energy into mechanical torque with higher efficiency. These systems are essential across sectors like automotive, robotics, manufacturing, and renewable energy, offering enhanced precision, power transmission, and performance. The market is strongly supported by the

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the